Telix Prescription drugs Restricted (TLX) Presents at H.C. Wainwright twenty seventh Annual International


Telix Prescription drugs Restricted (NASDAQ:TLX) H.C. Wainwright twenty seventh Annual International Funding Convention September 9, 2025 12:00 PM EDT

Firm Individuals

Christian Behrenbruch – Co-Founder, MD, Group CEO & Government Director

Convention Name Individuals

Robert Burns – H.C. Wainwright & Co, LLC, Analysis Division

Presentation

Robert Burns
Managing Director & Senior Healthcare Analyst

Welcome to our subsequent fireplace chat. I am Robert Burns, Managing Director and Senior Biotech Analyst, H.C. Wainwright. And I’m joined as we speak by Christian Behrenbruch, the CEO of Telix Prescription drugs. Christian, thanks for becoming a member of us as we speak.

Christian Behrenbruch
Co-Founder, MD, Group CEO & Government Director

Sure. Thanks for the chance.

Query-and-Reply Session

Robert Burns
H.C. Wainwright & Co, LLC, Analysis Division

So one of many issues that I first needed to start out off with was clearly, Telix has skilled fast development and transformation through the years. So are you able to share a few of the key components which have contributed to the success?

Christian Behrenbruch
Co-Founder, MD, Group CEO & Government Director

Effectively, I feel the corporate is simply actually keen about radiopharmaceuticals. I feel one of many distinctive facets in regards to the firm is we do not actually consider in isotope platforms, proper? We expect that whenever you develop a radiopharmaceutical, you need to have a look at the scientific utility that you simply need to clear up.

It is best to take into consideration what pharmacophore achieves your organic goals finest. After which you need to select the appropriate isotope for the job. And so one of many issues that I feel is admittedly particular in regards to the firm, and it is mirrored within the infrastructure that we have constructed over the past — virtually — firm is sort of 10 years outdated, 8 years as a public firm is that agnosticism.

We would like a — we’re very — we’re a pure-play radio pharma firm. We consider that precision drugs is admittedly essential. That is form of one thing that is not



Source link

Related articles

7 takeaways from the September FOMC

A brand new mountaineering cycle, alongside an upward revision to the Fed's longer run impartial price estimate, factors to a better for longer price atmosphere than markets had been pricing coming into the...

Payward Needs to Put US-Regulated Perpetual Futures on Hyperliquid

Payward plans to deliver US-regulated perpetual futures to Hyperliquid’s on-chain order guide. The markets would use Hyperliquid’s infrastructure, however entry, clearing and administration would stick with Payward’s regulated Bitnomial and NinjaTrader entities.London's buying...

Co-Diagnostics, Inc. (CODX) Shareholder/Analyst Name Transcript

Unknown Government Good morning, everybody. Thanks for becoming a member of us right here in New York on the webcast and in individual. At present, Dwight Egan, Chief Government Officer of Co-Diagnostics,...

MindsEye Developer Construct A Rocket Boy Is Reportedly Shutting Down

A number of workers have stated they're leaving the studio. ...

TradingView Provides MCP as Retail Brokers Undertake AI Buying and selling Instruments

FX Share of Retail Dealer Quantity Falls; Your Bourse Opens a New Workplace FX Share of Retail Dealer Quantity...
spot_img

Latest articles

LEAVE A REPLY

Please enter your comment!
Please enter your name here

WP2Social Auto Publish Powered By : XYZScripts.com